Ackman's Amends Valeant Pharma (VRX) 13D to Add Director Consent for MCTO
Tweet Send to a Friend
Bill Ackman amends his 13D on Valeant Pharma (NYSE: VRX). The amendment adds the following:In connection with the Issuer’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
